Tron Logo
Trade on HitBTC
Like this video

Team Embleema

Empowering Patients to Own Their Health Data

Embleema’s blockchain network offers a novel way to put patients at the center of clinical research by letting them own their health data, disrupting the slow, costly, manual and opaque process by which low quality health data is currently collected by pharmaceutical companies through Contrat Research Organisation, to monitor the efficacy of new investigational drugs. Connecting patients directly to medical research and incentivizing them to share their data with tokens, blockchain is the decentralized technology everyone was waiting for to move away from the current linear process of drug approvals, to a new iterative model where trustworthy digital health data is shared in real time between patients, life sciences and regulators. The 21st Century Cures Act (2016) gave the FDA a mandate to accelerate approvals if more patient real world data was shared proactively by pharma. Embleema's blockchain speeds up this process with patient buy-in, accelerating time to market new drugs.

4.2
7 6 expert ratings
Benchy 3.9
KYC
Experts
4.6
4.5
4.1
Review: coming soon PRO
Unknown
Token
RWE
Type
Price
1 RWE = 0.2 USD
Bounty
MVP/Prototype
Platform
Accepting
BTC, ETH, BCH, Fiat
Soft cap
2,000,000 USD
Hard cap
30,000,000 USD
Country
Whitelist/KYC
KYC
Restricted areas
USA, Canada, China, Iran, Sudan, Syria, North Korea, Crimea, New Zealand, Cuba
Visit ICO website
Report

Team

Apply as an advisor

Advisor

Dr. Vahan Simonyan

Chief Scientific Advisor, former R&D Director of Bioinformatics at the FDA

Pr. John Halamka, MD

CIO of Beth Israel, Pr. of Innovation at Harvard

Bernard Gilly, PhD

CEO of iBionext - Pixum -

Frédéric Duchesne, Pharm.D

CEO of Pierre Fabre Pharmaceuticals

Adel B. Al-Saleh

CEO T-Systems

Team

Robert Chu

CEO and CTO, former head of IMS / IQVIA in France & China, SVP of Technology Solutions

Alexis Normand

Head of Embleema Consortium, former Head of B2B Nokia Digital health / Withings

38 age

Pradeep Sreekanthan

Chief Delivery Officer, Former Director at IMS Health

Prashant Khambekar, Ph.D

Chief Development Executive, SVP Harbringer Systems

Nicolas Schmidt

Chief Product Officer, former head of Healthcare Products at Nokia

Vincent Galand

Operations Manager France

Lorenzo Nardiello

Social Media Manager

28 age

Xavier Lavayssière

Blockchain Regulation and Smart Contracts Expert

32 age

Munair Simpson

ICO & Crypto Expert - Asia

44 age

Add to bookmarks
ICO KYC Report
2 members invited
Robert Chu
Passed
Prashant Khambekar
Passed
KYC procedure verifies selected/specific team members only. It does not guarantee ICO success nor is a call for investment.
Missing or incorrect data? Let us know.

ICOs that might interest you

4.0

GOVEARN

We are building a global marketplace fintech based blockchain network with user friendl...

32 days 0 hours left
3.9

MADANA

MADANA is a platform for data analysis that uses Blockchain technology allowing partici...

4.1

MEDICOHEALTH

Medicohealth Platform will allow for fully anonymous, safe, and efficient communication...

4.1

HighVibe.Network

HighVibe.Network is a blockchain-based ecosystem designed to elevate human consciousnes...

Cookies help us deliver our services. By using our services, you agree to our use of cookies.

Learn more Got it